Evidence map›Paper›PMID 25612317›Full record

Trial reportPloS one2015

Height and bone mineral density are associated with naevus count supporting the importance of growth in melanoma susceptibility.

Simone Ribero, Daniel Glass, Abraham Aviv, Timothy David Spector, Veronique Bataille

Open access · goldAbstract readClinical TrialTwin Study
In one paragraph

Trial report in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Simone RiberoDepartment of Twin Research & Genetic Epidemiology, King's College London, United Kingdom; Section of Dermatology, Departments of Medical Sciences, University of Turin, Turin, Italy.
Daniel GlassDepartment of Twin Research & Genetic Epidemiology, King's College London, United Kingdom; Dermatology Department, Northwick Park Hospital, Middlesex, United Kingdom.
Abraham AvivCentre of Human Development and Ageing, University of Medicine and Dentistry of New Jersey, Newark, New Jersey, United States of America.
Timothy David SpectorDepartment of Twin Research & Genetic Epidemiology, King's College London, United Kingdom.
Veronique BatailleDepartment of Twin Research & Genetic Epidemiology, King's College London, United Kingdom; Dermatology Department, West Herts NHS Trust, Herts, United Kingdom.
King's College London · GBNorthwick Park Hospital · GBUniversity Hospital, Newark · USUniversity of Turin · IT

Funding

Wellcome Trust
6 · The paper itself

Abstract

Naevus count is the strongest risk factor for melanoma. Body Mass Index (BMI) has been linked to melanoma risk. In this study, we investigate the link between naevus count and height, weight and bone mineral density (BMD) in the TwinsUK cohort (N = 2119). In addition we adjusted for leucocyte telomere length (LTL) as LTL is linked to both BMD and naevus count. Naevus count was positively associated with height (p = 0.001) but not with weight (p = 0.187) despite adjusting for age and twin relatedness. This suggests that the previously reported melanoma association with BMI may be explained by height alone. Further adjustment for LTL did not affect the significance of the association between height and naevus count so LTL does not fully explain these results. BMD was associated with naevus count at the spine (coeff 18.9, p = 0.01), hip (coeff = 18.9, p = 0.03) and forearm (coeff = 32.7, p = 0.06) despite adjusting for age, twin relatedness, weight, height and LTL. This large study in healthy individuals shows that growth via height, probably in early life, and bone mass are risk factors for melanoma via increased naevus count. The link between these two phenotypes may possibly be explained by telomere biology, differentiation genes from the neural crests but also other yet unknown factors which may influence both bones and melanocytes biology.

Indexed as

Body HeightBone DensityMelanomaNevusSkin NeoplasmsAdultAgedBiometryFemaleHumansMaleMiddle AgedRisk FactorsTwins, DizygoticTwins, Monozygotic

Identifiers

PMID25612317
PMCPMC4303431
OpenAlexW2052916580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.